nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Enoxaparin is a cost-effective adjunct to fibrinolytic therapy for ST-elevation myocardial infarction in contemporary practice
|
Menown, Ian |
|
2010 |
27 |
3 |
p. 181-191 |
artikel |
2 |
Erratum to: Challenge with hepatitis B vaccine in children previously vaccinated with a hepatitis B-containing combination vaccine
|
Reinert, Philippe |
|
2010 |
27 |
3 |
p. 192 |
artikel |
3 |
Ivabradine: from molecular basis to clinical effectiveness
|
Riccioni, Graziano |
|
2010 |
27 |
3 |
p. 160-167 |
artikel |
4 |
PF-03475952: a potent and neutralizing fully human anti-CD44 antibody for therapeutic applications in inflammatory diseases
|
Runnels, Herbert A. |
|
2010 |
27 |
3 |
p. 168-180 |
artikel |
5 |
The platinum chromium element stent platform: from alloy, to design, to clinical practice
|
Menown, Ian B. A. |
|
2010 |
27 |
3 |
p. 129-141 |
artikel |
6 |
The short, the long and the “ultra-long”: Why duration of bronchodilator action matters in chronic obstructive pulmonary disease
|
Beeh, Kai M. |
|
2010 |
27 |
3 |
p. 150-159 |
artikel |
7 |
Treatment of primary immunodeficiency with Kiovig®: a literature review
|
Simoens, Steven |
|
2010 |
27 |
3 |
p. 142-149 |
artikel |